CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Distributions in Excess of Net Income	Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2024		305,492
Beginning balance at Dec. 31, 2024	$ 2,983,922	$ 3,055	$ 3,431,043	$ 8,218	$ (458,638)	$ 244
Increase (Decrease) in Equity [Roll Forward]
Common stock dividends	(88,492)				(88,492)
Equity based compensation expense	4,650		4,650
Other comprehensive income (loss)	(4,143)			(4,143)
Issuance of common stock, net of issuance costs (in shares)		568
Issuance of common stock, net of issuance costs	0	$ 6	(6)
Repurchases of common shares in conjunction with equity award plans	(11,645)		(11,645)
Net income	69,737				69,729	8
Ending balance (in shares) at Mar. 31, 2025		306,060
Ending balance at Mar. 31, 2025	2,954,029	$ 3,061	3,424,042	4,075	(477,401)	252
Beginning balance (in shares) at Dec. 31, 2025		306,105
Beginning balance at Dec. 31, 2025	3,010,056	$ 3,061	3,437,853	1,722	(432,822)	242
Increase (Decrease) in Equity [Roll Forward]
Common stock dividends	(94,811)				(94,811)
Equity based compensation expense	2,636		2,636
Other comprehensive income (loss)	7,687			7,687
Issuance of common stock, net of issuance costs (in shares)		732
Issuance of common stock, net of issuance costs	0	$ 7	(7)
Repurchases of common shares in conjunction with equity award plans	(16,412)		(16,412)
Net income	127,757				127,750	7
Ending balance (in shares) at Mar. 31, 2026		306,837
Ending balance at Mar. 31, 2026	$ 3,036,913	$ 3,068	$ 3,424,070	$ 9,409	$ (399,883)	$ 249